Organization
University of Leipzig
10 clinical trials
Clinical trial
Cholangiocarcinoma Treatment With Radiofrequency Ablation or Photodynamic Therapy: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2028-04-01
Clinical trial
Randomized Phase III Study Comparing the OSHO Arm to the Standard Intergroup Arm.Status: Completed, Estimated PCD: 2018-07-18
Clinical trial
The Pancreatic Enzymes After Gastrectomy TrialStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Phase II, Open-label, Single Arm Study to Evaluate the Efficacy of Luspatercept in Erythropoiesis-stimulating Agent Naive Lower-risk MDS Patients With or Without Ring Sideroblasts Who do Not Require RBC TransfusionsStatus: Recruiting, Estimated PCD: 2026-07-31
Clinical trial
Postoperative Adjuvant Radiochemotherapy (aRCH) With Cisplatin (C) Versus aRCH With C and Pembrolizumab (P) in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC); Multicenter Randomized Phase II Study Within the German Interdisciplinary Study Group of German Cancer Society (IAG KHT); Pembro-Adjuvant-highRiskStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Single-arm, Pilot Study of Venetoclax in Combination With 5 Days Azacitidine in Treatment-naïve Subjects With Acute Myelogenous Leukemia Who Are ≥18 Years of Age and Not Eligible for Standard Induction Therapy (VENAZA-5S PILOT TRIAL)Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Phase II, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Canakinumab for the Treatment of Anemia in Patients With IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes or MDS/MPNStatus: Terminated, Estimated PCD: 2024-02-29
Clinical trial
A Phase II, Open-Label, Multicenter Study of Orally Administered CA-4948 for the Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS)Status: Terminated, Estimated PCD: 2024-03-06
Clinical trial
Hemodynamic Effects of Angiotensin Receptor Neprilysin Inhibition on Noninvasive Pressure-volume Analysis in Patients With Heart Failure With Reduced Ejection FractionStatus: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
ELOS - Induction Chemotherapy With Docetaxel and Cisplatin Followed by Radiation Compared to Additional PD-1 Inhibition in CPS ≥1 Advanced Laryngeal/Hypopharyngeal Cancer Suitable for Laryngectomy Selected After Early Response EvaluationStatus: Not yet recruiting, Estimated PCD: 2028-12-01